CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 45 filers reported holding CYTOSORBENTS CORP in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $393,000 | +67.9% | 30,500 | +48.8% | 0.00% | – |
Q2 2018 | $234,000 | +70.8% | 20,500 | +5.1% | 0.00% | – |
Q1 2018 | $137,000 | +39.8% | 19,500 | +30.0% | 0.00% | – |
Q4 2017 | $98,000 | -21.0% | 15,000 | -25.0% | 0.00% | – |
Q3 2017 | $124,000 | -23.9% | 20,000 | -47.4% | 0.00% | – |
Q2 2017 | $163,000 | +132.9% | 38,000 | +145.2% | 0.00% | – |
Q1 2017 | $70,000 | +27.3% | 15,500 | +55.0% | 0.00% | – |
Q4 2016 | $55,000 | -14.1% | 10,000 | 0.0% | 0.00% | – |
Q3 2016 | $64,000 | +39.1% | 10,000 | -2.0% | 0.00% | – |
Q2 2016 | $46,000 | +53.3% | 10,200 | +32.5% | 0.00% | – |
Q1 2016 | $30,000 | +15.4% | 7,700 | +63.8% | 0.00% | – |
Q4 2015 | $26,000 | +2500.0% | 4,700 | +2250.0% | 0.00% | – |
Q3 2015 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2015 | $1,000 | -66.7% | 200 | 0.0% | 0.00% | – |
Q1 2015 | $3,000 | +200.0% | 200 | +100.0% | 0.00% | – |
Q4 2014 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
Avenir Corp | 76,390 | $617,000 | 0.08% |
Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |